share_log

Bellerophon Therapeutics | SC 13G: Statement of acquisition of beneficial ownership by individuals-507 Summit LLC(8.4%),Lepercq Capital Management LLC(8.4%), etc.

Bellerophon Therapeutics | SC 13G:超过5%持股股东披露文件-507 Summit LLC(8.4%),Lepercq Capital Management LLC(8.4%)等

SEC announcement ·  01/26 10:49
声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息